Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
15,708,880
-
Shares change
-
+978,794
-
Total reported value, excl. options
-
$334,123,652
-
Value change
-
+$20,098,383
-
Put/Call ratio
-
364%
-
Number of buys
-
59
-
Number of sells
-
-25
-
Price
-
$21.27
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q2 2015
92 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q2 2015.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,708,880 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4,190,594 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,452,128 shares), RA CAPITAL MANAGEMENT, LLC (1,026,402 shares), FMR LLC (1,000,000 shares), JPMORGAN CHASE & CO (924,357 shares), FRANKLIN RESOURCES INC (850,300 shares), PERCEPTIVE ADVISORS LLC (552,628 shares), MILLENNIUM MANAGEMENT LLC (526,583 shares), Point72 Asset Management, L.P. (505,200 shares), and Citadel Advisors LLC (449,488 shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.